These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 37394766)
1. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway. Liu Y; Yang H Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766 [TBL] [Abstract][Full Text] [Related]
2. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway. Zhang Y; Chen X Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821 [TBL] [Abstract][Full Text] [Related]
3. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1. Yang C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y J Obstet Gynaecol Res; 2021 Nov; 47(11):4037-4048. PubMed ID: 34378285 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
5. LINC02381 aggravates breast cancer through the miR-1271-5p/FN1 axis to activate PI3K/AKT pathway. Huang S; Huang P; Wu H; Wang S; Liu G Mol Carcinog; 2022 Mar; 61(3):346-358. PubMed ID: 34882856 [TBL] [Abstract][Full Text] [Related]
6. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway. Chen M; Zhang J J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway. Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689 [TBL] [Abstract][Full Text] [Related]
9. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance. Wang X; Jiang L; Liu Q J Transl Med; 2022 Jun; 20(1):258. PubMed ID: 35672774 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway. Sun W; Zu S; Shao G; Wang W; Gong F J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171 [TBL] [Abstract][Full Text] [Related]
11. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
12. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway. Zhang J; Wang L; Jiang J; Qiao Z J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6. Liu Y; Liang G; Wang H; Liu Z Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
16. miR-660-5p promotes breast cancer progression through down-regulating TET2 and activating PI3K/AKT/mTOR signaling. Peng B; Li C; He L; Tian M; Li X Braz J Med Biol Res; 2020; 53(12):e9740. PubMed ID: 33146288 [TBL] [Abstract][Full Text] [Related]
17. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway. Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway. Cui FC; Chen Y; Wu XY; Hu M; Qin WS Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957 [TBL] [Abstract][Full Text] [Related]
19. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway. Han S; Chen Y; Gao Y; Sun B; Kong Y Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]